Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (73.7%); - neuroscience (20.6%); - rare diseases (5.7%). At the end of 2024, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide. Net sales are distributed geographically as follows: Europe (39.3%), North America (34.3%) and other (26.4%).